Clinical Trial

HiSCs in the Treatment of Rheumatoid Arthritis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This trial is a single-center, single-arm exploratory clinical study aimed at assessing the safety, tolerability, and preliminary efficacy of a single intra-articular injection of hiSCs for the treatment of rheumatoid arthritis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-23.
Status change: Not Yet Recruiting → Recruiting 2026-02-25
Trial Details
NCT Number NCT06947746
Lead Sponsor Shanghai Changzheng Hospital
Conditions Rheumatoid Arthritis (RA)
Enrollment 15 participants
Start Date 2025-05-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27